Thanks for posting the link @nathan1984, I would never have come across it otherwise.
This podcast is an absolutely superb and well packaged interview of two brilliant minds, GlyTherix CEO Dr Brad Walsh and Telix Pharmaceuticals CEO Dr Chris Behrenbruch, on current nuclear medicine opportunities and challenges.
For those that have not seen it and have even a modicum of an industry interest, taken the time to do so. Is well worth it. To extend your knowledge and understanding it is worth reading its predecessor as well, Phase II.
Worth noting the podcast platform and the content producers here have done an excellent job as well, credit to Rachel Williamson and Charis Palmer et al.
Thanks for posting the link @nathan1984, I would never have come...
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.56 |
Change
-0.410(1.96%) |
Mkt cap ! $6.951B | |||
| Open | High | Low | Value | Volume |
| $20.56 | $20.81 | $20.49 | $2.581M | 125.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 320 | $20.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.58 | 2231 | 16 |
View Market Depth
| Last trade - 11.51am 02/10/2024 (20 minute delay) ? |
| TLX (ASX) Chart |